Stock Legends

[AugustaFriends]

ACST 1.27 is valued at $10-15/share. -- Acasti recently pulled the trigger on a public raise for $23 million for 18.4 million units. Each unit consisted of one share and one warrant with an exercise price of $1.50. This allows Acasti to raise an addition $27.6 million in the future, resulting in potentially $50.6 million in cash to drive continued development in prescription-strength krill oil.

If Acasti is able to execute on its strategy for CaPre by attaining FDA approval, valuation should be able to rival Amarin's prior to its FDA advisory panel blow up, in the range of $800-1.2 billion by 2016. Correspondingly resulting in Acasti being valued at $10-15/share.

http://seekingalpha.com/article/1938471-while-amarin-continues-to-go-rancid-neptune-will-soar?source=marketwatch